Jenna H. Newman - Concepedia

Author

Jenna H. Newman

Rutgers, The State University of New Jersey ORCID

Also Known As

Jenna H Newman, Jenna H. Newman, Jenna Newman, Jenna H. Newman, Paul M. Harari, Praveen K. Bommareddy

Publications

709

Citations

H-Index

Concepts

All Affiliations

Rutgers, The State University of New Jersey Rush University Medical Center Rutgers Cancer Institute Dana-Farber Cancer Institute Harvard University

About

Jenna H. Newman is an author at Rutgers, The State University of New Jersey specializing in medicine, cell death, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	250
2	Cell Biology	2	2	221
3	Immunology	1	1	204
4	Pathology	1	1	29
5	Lung Inflammation	1	1	204

Jenna H. Newman

Publications

634

Citations

H-Index

Page 1

	Year	Citations
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer Matthew D. Park, Ivan Reyes-Torres, Jessica LeBérichel, Nature Immunology Lung InflammationMedicineImmunologyCell DeathNk Cell Paucity	2023	204
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer Jenna H. Newman, Charles B. Chesson, Nora L. Herzog, Proceedings of the National Academy of Sciences	2019	185
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment Jessica Wagner, C. Leah B. Kline, Lanlan Zhou, Journal of Clinical Investigation	2018	78
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration Mark N. Stein, Jyoti Malhotra, Rohinton S. Tarapore, Journal for ImmunoTherapy of Cancer	2019	70
Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death Frederick J. Kohlhapp, Erica Huelsmann, Andrew T. Lacek, Cell Reports Host ResponseAntiviral ResponsePathologyVirologyChronic Viral Infection	2016	29
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer Sachin R. Jhawar, Shang-Jui Wang, Aditya Thandoni, Journal for ImmunoTherapy of Cancer	2023	27
Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer Jenna H. Newman, David J. Augeri, Rachel NeMoyer, Oncogene Induces RegressionTumor Cell SurvivalMedicineCell DeathHuman Lung Cancer	2018	17
Structural basis for self-discrimination by neoantigen-specific TCRs John P. Finnigan, Jenna H. Newman, Y. Patskovsky, Nature Communications	2024	13
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma Ann W. Silk, Howard L. Kaufman, Brendan D. Curti, Frontiers in Oncology	2020	11

Page 1